Report #2834576

Received Apr 8, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 67 yrs
State: —
Recovered: Unknown
Vaccinated: Apr 2, 2025
Onset: Apr 2, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	4L5My	—

Symptoms (1)

Expired product administered

Symptom narrative

Arexvy less than 30 days expired dose administration; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 67-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 4L5My, expiry date 29-MAR-2025) for prophylaxis. On 02-APR-2025, the patient received Arexvy. On 02-APR-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Arexvy less than 30 days expired dose administration). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 03-APR-2025 Pharmacist wanted to know how to proceed after administering an expired dose of Arexvy which led to expired vaccine used. The health care provider requested to remain anonymous.